Figure S1. Percentage of HepG2 cell proliferation of FA treatment in the presence of different concentrations of MND (Percentage of cell proliferation was normalized by 0 μM of MND). 25 μM was the highest concentration of MND that did not reduce proliferation of untreated and FA treated cells. The asterisks indicate statistical difference. (JPG 59 kb
Figure S3. Representative images of EpCAM and β-Catenin in liver parenchyma in all 4 experimental g...
SILAC transVA-OA-CLA. Data from the SILAC investigation of the cellular response to transVA, OA and ...
Additional file 1: Figure S1. Deficiency of hepatocytes p65 attenuated hepatocellular carcinogenesis...
Figure S2. Carbonylation levels of ATP5A in FA treatment and FA/MND treatment. Western blot analysis...
Table S1. Carbonylated sites identified by mass spectrometry of carbonylated proteins detected with ...
Figure S2. The body weights, liver weights, serum and tissue triglyceride levels, alpha fetoprotein ...
Figure S3. MS/MS spectrum of ATP5A peptides showing carbonylation on K132 (A), R171 and K175 (B), an...
Figure S1. Quantification of intracellular lipid content over time. (A) The plotted graph depicts th...
Biochemical surrogate indices of impaired liver fat metabolism. In response to HFD, increased levels...
Figure S1. Cell proliferation of AT-Ex-treated cells. (a) NHF, (b) NHK, (c) NHM, and (d) ADSCs were ...
Figure S1. Representative image of collagen quantification after staining with Sirius red. Table S1....
Volcano plot [−log10 (p-value) vs. log2 (fold-change)] for the comparison between the baseline and f...
The severity of HFrD-mediated damage is higher in middle-aged A/A Hep mice. (a) The data (serum ALT ...
Figure S1. Ratio discrepancy of the target proteins/β-actin between HCC cells cultured in MRC-5-CM ...
Figure S3. Live cell imaging of LD growth induced by fusogen. (A) Depicted are live cell images of H...
Figure S3. Representative images of EpCAM and β-Catenin in liver parenchyma in all 4 experimental g...
SILAC transVA-OA-CLA. Data from the SILAC investigation of the cellular response to transVA, OA and ...
Additional file 1: Figure S1. Deficiency of hepatocytes p65 attenuated hepatocellular carcinogenesis...
Figure S2. Carbonylation levels of ATP5A in FA treatment and FA/MND treatment. Western blot analysis...
Table S1. Carbonylated sites identified by mass spectrometry of carbonylated proteins detected with ...
Figure S2. The body weights, liver weights, serum and tissue triglyceride levels, alpha fetoprotein ...
Figure S3. MS/MS spectrum of ATP5A peptides showing carbonylation on K132 (A), R171 and K175 (B), an...
Figure S1. Quantification of intracellular lipid content over time. (A) The plotted graph depicts th...
Biochemical surrogate indices of impaired liver fat metabolism. In response to HFD, increased levels...
Figure S1. Cell proliferation of AT-Ex-treated cells. (a) NHF, (b) NHK, (c) NHM, and (d) ADSCs were ...
Figure S1. Representative image of collagen quantification after staining with Sirius red. Table S1....
Volcano plot [−log10 (p-value) vs. log2 (fold-change)] for the comparison between the baseline and f...
The severity of HFrD-mediated damage is higher in middle-aged A/A Hep mice. (a) The data (serum ALT ...
Figure S1. Ratio discrepancy of the target proteins/β-actin between HCC cells cultured in MRC-5-CM ...
Figure S3. Live cell imaging of LD growth induced by fusogen. (A) Depicted are live cell images of H...
Figure S3. Representative images of EpCAM and β-Catenin in liver parenchyma in all 4 experimental g...
SILAC transVA-OA-CLA. Data from the SILAC investigation of the cellular response to transVA, OA and ...
Additional file 1: Figure S1. Deficiency of hepatocytes p65 attenuated hepatocellular carcinogenesis...